Calgary, Alberta and Tel Aviv, Israel–(Newsfile Corp. – June 5, 2020) – InnoCan Pharma (CSE: INNO) (“InnoCan” or the “Company“) is pleased to announce the commencement of commercial production if Derma CBD line in Portugal. The first product which are currently manufactured is The Patent Pending Relief & Go CBD Spray, one of InnoCan’s flagship products, developed by chief technology officer Nir Avram.

Nir Avram the company’s CTO T commented: “The patent pending unique formulation of Relief & Go CBD Spray contains CBD isolate as anti inflammatory, magnesium as muscle relaxant, menthol and camphor as analgesics to provide temporary relief of muscle and joint pain, before and after sports activity. I believe, this is an affective product, which will be very successful in the market”.

To view the source version of this press release, please visit

Powered by WPeMatico